Answers are grounded in this paper and cite their sources.
The current outbreak of COVID-19 pandemic traces its roots back many decades and is worsened by a number of ill-conceived strategies and policies. The current patent protection regime and its suitability in dealing with the current COVID-19 pandemic need to be questioned. Strengthened intellectual property protection manifested by the rise of TRIPS-Plus standards is having a negative impact on the affordability and accessibility of medicines. Dealing with the current pandemic urgently demands serious reform and collective efforts.
No takes yet. Share an insight, caveat, or question.
Mohammed Said (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: